Compound heterozygous RHCE null genotype underlying D−− phenotype in a Chinese pregnant woman: molecular characterization and sequential transfusion strategy
4 affiliations
- 1Department of Blood Transfusion, Shandong Provincial Hospital Affiliated to Shandong First Medical University
- 2Shandong Blood Center
- 3Department of Obstetrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University
- 4Department of Vascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University
Abstract
The D−− phenotype is an extremely rare Rh blood group variant with absence of C, c, E, and e antigens but preserved D expression, predisposing to anti-Rh17 alloimmunization and hemolytic disease of fetus and newborn (HDFN). We report a 25-year-old Chinese woman (gravida 3, para 1) with D+C−c−E−e− phenotype and a history of severe neonatal jaundice and fetal demise. In her current pregnancy, admitted at 25 ⁺⁵ weeks for elevated fetal middle cerebral artery peak systolic velocity. PacBio sequencing (proband and her parents) and Oxford Nanopore whole-genome sequencing (ONT WGS; proband) were performed. PacBio sequencing preliminarily identified a compound heterozygous state at the RHCE locus involving two distinct RHCE -null haplotypes, a paternal complex structural variant and a maternal RHCE*02N.03 null allele with seven mutations. Subsequent ONT WGS resolved a novel paternal chimeric RHD–TMEM50A–RHCE rearrangement arising from dual recombination events. Serological and family evidence suggest that the maternal RHCE*02N.03 allele with c.486 + 1G>A results in a C−e− null phenotype in the compound heterozygous state. Four serial intrauterine transfusions used allogeneic D−− donor blood or maternal autologous washed irradiated packed red blood cells. All transfusions were well tolerated, with delivery at 37 weeks by cesarean section and favorable neonatal outcomes. This case demonstrates a sequential transfusion strategy for D−− pregnancies—prioritizing allogeneic D−− blood from rare donor networks when available, with maternal autologous blood as a safe alternative—and, through complementary PacBio and ONT WGS, adds evidence that complex RHD-RHCE inversion-recombination events may represent recurret mechanisms in the Chinese population while refining RHCE*02N.03 annotation from C− to C−e−.
Related
- Novel Compound Heterozygous CEP152 Variants Associated with Atypical Seckel Syndrome 5 in a Chinese Child: Functional Characterization of a Novel Splice-Site Variant and Expansion of the Genotype-Phenotype Spectrum.
- Genotype-phenotype analysis in 333 individuals with heterozygous variants in NFKB1.
- Neural Mechanisms Underlying Metacognitive Processes in Sequential Decision-Making
- Isolation, identification, and slow-growth phenotype characterization of a clinically derived Escherichia coli from urinary tract infection
- Whole-genome sequencing-based characterization of antimicrobial resistance determinants and phenotype–genotype concordance in uropathogenic Escherichia coli isolates from ICU patients in Saudi Arabia
BibTeX
@article{zhou2026compound,
title = {{Compound heterozygous RHCE null genotype underlying D−− phenotype in a Chinese pregnant woman: molecular characterization and sequential transfusion strategy}},
author = {Wenjing Zhou and Li An and Lei Li and Haiyan Wan and Wangnan Sun and Qi He and Na Zhao and Mo Wang and Shouyong Hun},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.2004196},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2004196/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Compound heterozygous RHCE null genotype underlying D−− phenotype in a Chinese pregnant woman: molecular characterization and sequential transfusion strategy
AU - Wenjing Zhou
AU - Li An
AU - Lei Li
AU - Haiyan Wan
AU - Wangnan Sun
AU - Qi He
AU - Na Zhao
AU - Mo Wang
AU - Shouyong Hun
PY - 2026
DA - 2026/10/15
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.2004196
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2004196/full
AB - The D−− phenotype is an extremely rare Rh blood group variant with absence of C, c, E, and e antigens but preserved D expression, predisposing to anti-Rh17 alloimmunization and hemolytic disease of fetus and newborn (HDFN). We report a 25-year-old Chinese woman (gravida 3, para 1) with D+C−c−E−e− phenotype and a history of severe neonatal jaundice and fetal demise. In her current pregnancy, admitted at 25 ⁺⁵ weeks for elevated fetal middle cerebral artery peak systolic velocity. PacBio sequencing (proband and her parents) and Oxford Nanopore whole-genome sequencing (ONT WGS; proband) were performed. PacBio sequencing preliminarily identified a compound heterozygous state at the RHCE locus involving two distinct RHCE -null haplotypes, a paternal complex structural variant and a maternal RHCE*02N.03 null allele with seven mutations. Subsequent ONT WGS resolved a novel paternal chimeric RHD–TMEM50A–RHCE rearrangement arising from dual recombination events. Serological and family evidence suggest that the maternal RHCE*02N.03 allele with c.486 + 1G>A results in a C−e− null phenotype in the compound heterozygous state. Four serial intrauterine transfusions used allogeneic D−− donor blood or maternal autologous washed irradiated packed red blood cells. All transfusions were well tolerated, with delivery at 37 weeks by cesarean section and favorable neonatal outcomes. This case demonstrates a sequential transfusion strategy for D−− pregnancies—prioritizing allogeneic D−− blood from rare donor networks when available, with maternal autologous blood as a safe alternative—and, through complementary PacBio and ONT WGS, adds evidence that complex RHD-RHCE inversion-recombination events may represent recurret mechanisms in the Chinese population while refining RHCE*02N.03 annotation from C− to C−e−.
SN - 1664-3224
ER -